Drug profile · INN
sebetralstat
EKTERLY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sebetralstat (EKTERLY) is an FDA-listed pharmaceutical active ingredient. Associated with Kalvista Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sebetralstat
Brand EKTERLY
Route ORAL
Formulation TABLET
ATC code B06AC08
Originator Kalvista Pharmaceuticals (Ireland) Limited
Frequently asked questions
What is sebetralstat?
sebetralstat (EKTERLY) is an FDA-listed pharmaceutical active ingredient. Associated with Kalvista Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sebetralstat?
EKTERLY is a marketed brand name for sebetralstat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sebetralstat?
sebetralstat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.